By generating oxygen inside the implant, scientists significantly improved cell survival and sustained multi-drug delivery over 30 days.

In their latest research, scientists showed the HOBIT implant could remain effective inside rats for at least a month.

The global insulin delivery devices market is experiencing strong expansion as the prevalence of diabetes continues to rise worldwide. Insulin delivery devices play a crucial role in managing blood ...

NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new ...

PharmaJet's Needle-free intradermal (ID) injection device ("Tropis(R) ID") will be evaluated as delivery system for the tuberculin skin test (TST) in a clinical study conducted by REDE-TB. -- The ...

PharmaJet's Needle-free Tropis is being evaluated in a clinical study by REDE-TB as a potential improvement on the TB skin ...

According to the in-depth market research report published by MarkNtel Advisors, the Wearable Health Devices Market in GCC is projected to grow at a CAGR of around 14.7% during 2026–2032, reflecting ...

A video documents attempts to fix a vintage 20-inch Trinitron CRT suffering from cataracts by injecting UV resin.

India, March 21 -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, ...

Sun Pharmaceutical Industries has announced the launch of its semaglutide injection in India under the brand names Noveltreat and Sematrinity, across multiple strengths for the treatment of obesity ...

Doctors explain the differences between the Wegovy pill and injection in terms of efficacy, side effects, and more. They ...

Embecta (Nasdaq:EMBC) announced today that it entered into a definitive agreement to acquire Owen Mumford Holdings Limited.